{
    "clinical_study": {
        "@rank": "107573", 
        "arm_group": [
            {
                "arm_group_label": "Montelukast/Placebo", 
                "arm_group_type": "Experimental", 
                "description": "Participants receive montelukast 5 mg chewable tablets for 7 days during Period 1 and receive placebo chewable tablets for 7 days during Period 2. There is a 7-day washout period between Periods 1 and 2."
            }, 
            {
                "arm_group_label": "Placebo/Montelukast", 
                "arm_group_type": "Experimental", 
                "description": "Participants receive placebo chewable tablets for 7 days during Period 1 and receive montelukast 5 mg chewable tablets for 7 days during Period 2. There is a 7-day washout period between Periods 1 and 2."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will evaluate the efficacy and safety of montelukast (MK-0476) in the treatment\n      of Japanese pediatric participants with seasonal allergic rhinitis (SAR). The primary\n      hypothesis of this study is that montelukast is superior to placebo in the treatment of\n      nasal symptoms in SAR."
        }, 
        "brief_title": "Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Participants receive montelukast 5 mg chewable tablets for 7 days during Period 1 and receive placebo chewable tablets for 7 days during Period 2. There is a 7-day washout period between Periods 1 and 2.", 
                            "title": "Montelukast/Placebo"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Participants receive placebo chewable tablets for 7 days during Period 1 and receive montelukast 5 mg chewable tablets for 7 days during Period 2. There is a 7-day washout period between Periods 1 and 2.", 
                            "title": "Placebo/Montelukast"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "110"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "110"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "220"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@lower_limit": "10", 
                                                "@spread": "1.6", 
                                                "@upper_limit": "15", 
                                                "@value": "12.3"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@lower_limit": "10", 
                                                "@spread": "1.5", 
                                                "@upper_limit": "15", 
                                                "@value": "12.7"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@lower_limit": "10", 
                                                "@spread": "1.6", 
                                                "@upper_limit": "15", 
                                                "@value": "12.5"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "55"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "51"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "106"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "55"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "59"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "114"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-0.11", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "0.10", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "Longitudinal Data Analysis (LDA)", 
                                "non_inferiority": "No", 
                                "p_value": "0.913", 
                                "p_value_desc": "Longitudinal Data Analysis (LDA) model with baseline TNSS as a covariate, sequence, treatment and period as fixed effects and participant as a random effect.", 
                                "param_type": "Difference in Least Squares (LS) Means", 
                                "param_value": "-0.01"
                            }
                        }, 
                        "description": "The TNSS is the sum of the three nasal symptom scores for nasal congestion, nasal discharge and sneezing. Participants completed a questionnaire about their nasal symptoms. Score ranged from 0 to 4 for each of the three nasal symptoms, with a total possible score ranging from 0 to 12 and a higher score indicating more severe nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period during 3 hours of exposure to Japanes cedar (JC) pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "1.03", 
                                                        "@upper_limit": "1.31", 
                                                        "@value": "1.17"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "1.04", 
                                                        "@upper_limit": "1.32", 
                                                        "@value": "1.18"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The TNSS is the sum of the three nasal symptom scores for nasal congestion, nasal discharge and sneezing. Participants completed a questionnaire about their nasal symptoms. Score ranged from 0 to 4 for each of the three nasal symptoms, with a total possible score ranging from 0 to 12 and a higher score indicating more severe nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period during 3 hours of exposure to Japanes cedar (JC) pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Total Nasal Symptom Score (TNSS) Averaged During 3 Hours of Exposure", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The Full Analysis Set (FAS) population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period", 
                        "title": "Change From Baseline in Total Nasal Symptom Score (TNSS) Averaged During 3 Hours of Exposure", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "An adverse event is defined as any unfavorable and unintended change in the structure, function, or chemistry of the body temporally associated with the use of the study drug, whether or not considered related to the use of the product. Participants were monitored for occurrence adverse events for up to 14 days after last dose of study drug. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "216"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "218"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "22"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "36"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "An adverse event is defined as any unfavorable and unintended change in the structure, function, or chemistry of the body temporally associated with the use of the study drug, whether or not considered related to the use of the product. Participants were monitored for occurrence adverse events for up to 14 days after last dose of study drug. Analysis was done by study drug as taken.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants Who Experience at Least One Adverse Event", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "population": "The All Patients as Treated (APaT) population consisted of all randomized participants who received at least one dose of study drug.", 
                        "safety_issue": "Yes", 
                        "time_frame": "Up to 5 weeks", 
                        "title": "Percentage of Participants Who Experience at Least One Adverse Event", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-0.17", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "0.16", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "LDA", 
                                "non_inferiority": "No", 
                                "p_value": "0.953", 
                                "p_value_desc": "Longitudinal Data Analysis (LDA) model with baseline Weighted TNSS as a covariate, sequence, treatment and period as fixed effects and participant as a random effect.", 
                                "param_type": "Difference in LS Means", 
                                "param_value": "-0.00"
                            }
                        }, 
                        "description": "TNSS was weighted as 2:1:1 for nasal congestion, nasal discharge and sneezing. The Weighted TNSS ranged from 0 to 16, with a higher score indicating more severe weighted total nasal symptoms. The baseline Weighted TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "1.63", 
                                                        "@upper_limit": "2.07", 
                                                        "@value": "1.85"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "1.63", 
                                                        "@upper_limit": "2.08", 
                                                        "@value": "1.86"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "TNSS was weighted as 2:1:1 for nasal congestion, nasal discharge and sneezing. The Weighted TNSS ranged from 0 to 16, with a higher score indicating more severe weighted total nasal symptoms. The baseline Weighted TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Weighted TNSS Averaged During 3 Hours of Exposure", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period", 
                        "title": "Change From Baseline in Weighted TNSS Averaged During 3 Hours of Exposure", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-0.07", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "0.07", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "LDA", 
                                "non_inferiority": "No", 
                                "p_value": "0.974", 
                                "p_value_desc": "Longitudinal Data Analysis (LDA) model with baseline nasal congestion score as a covariate, sequence, treatment and period as fixed effects and participant as a random effect.", 
                                "param_type": "Difference in LS Means", 
                                "param_value": "-0.00"
                            }
                        }, 
                        "description": "The Nasal Congestion Score was assessed as 0 = No symptoms of nasal congestion to 4 = Completely obstructed all day, with a possible Nasal Congestion Score ranging from 0 to 4 and a higher score indicating more severe nasal congestion. The baseline Nasal Congestion Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Nasal Congestion Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.59", 
                                                        "@upper_limit": "0.76", 
                                                        "@value": "0.68"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.59", 
                                                        "@upper_limit": "0.76", 
                                                        "@value": "0.68"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The Nasal Congestion Score was assessed as 0 = No symptoms of nasal congestion to 4 = Completely obstructed all day, with a possible Nasal Congestion Score ranging from 0 to 4 and a higher score indicating more severe nasal congestion. The baseline Nasal Congestion Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Nasal Congestion Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Nasal Congestion Score Averaged During 3 Hours of Exposure", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period", 
                        "title": "Change From Baseline in Nasal Congestion Score Averaged During 3 Hours of Exposure", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-0.06", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "0.01", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "LDA", 
                                "non_inferiority": "No", 
                                "p_value": "0.182", 
                                "p_value_desc": "Longitudinal Data Analysis (LDA) model with baseline nasal discharge score as a covariate, sequence, treatment and period as fixed effects and participant as a random effect.", 
                                "param_type": "Difference in LS Means", 
                                "param_value": "-0.03"
                            }
                        }, 
                        "description": "The Nasal Discharge Score was assessed as 0 = 0 times participant blew his/her nose to 4 = 21 or more times participant blew his/her nose, with a possible Nasal Discharge Score ranging from 0 to 4 and a higher score indicating more severe nasal discharge. The baseline Nasal Discharge Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Nasal Discharge Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.25", 
                                                        "@upper_limit": "0.34", 
                                                        "@value": "0.29"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.27", 
                                                        "@upper_limit": "0.37", 
                                                        "@value": "0.32"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The Nasal Discharge Score was assessed as 0 = 0 times participant blew his/her nose to 4 = 21 or more times participant blew his/her nose, with a possible Nasal Discharge Score ranging from 0 to 4 and a higher score indicating more severe nasal discharge. The baseline Nasal Discharge Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Nasal Discharge Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Nasal Discharge Score Averaged During 3 Hours of Exposure", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period", 
                        "title": "Change From Baseline in Nasal Discharge Score Averaged During 3 Hours of Exposure", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-0.01", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "0.05", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "LDA", 
                                "non_inferiority": "No", 
                                "p_value": "0.161", 
                                "p_value_desc": "Longitudinal Data Analysis (LDA) model with baseline sneezing score as a covariate, sequence, treatment and period as fixed effects and participant as a random effect.", 
                                "param_type": "Difference in LS Means", 
                                "param_value": "0.02"
                            }
                        }, 
                        "description": "The Sneezing Score was assessed as 0 = 0 times participant sneezed to 4 = 21 or more times participant sneezed, with a possible Sneezing Score ranging from 0 to 4 and a higher score indicating more severe sneezing. The baseline Sneezing Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Sneezing Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.16", 
                                                        "@upper_limit": "0.24", 
                                                        "@value": "0.20"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.14", 
                                                        "@upper_limit": "0.22", 
                                                        "@value": "0.18"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The Sneezing Score was assessed as 0 = 0 times participant sneezed to 4 = 21 or more times participant sneezed, with a possible Sneezing Score ranging from 0 to 4 and a higher score indicating more severe sneezing. The baseline Sneezing Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Sneezing Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Sneezing Score Averaged During 3 Hours of Exposure", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period", 
                        "title": "Change From Baseline in Sneezing Score Averaged During 3 Hours of Exposure", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The TNSS is the sum of the three nasal symptom scores for nasal congestion, nasal discharge and sneezing. The possible TNSS ranged from 0 to 12, with a higher score indicting more severe total nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.42", 
                                                            "@upper_limit": "0.67", 
                                                            "@value": "0.54"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.46", 
                                                            "@upper_limit": "0.71", 
                                                            "@value": "0.59"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "30 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.84", 
                                                            "@upper_limit": "1.16", 
                                                            "@value": "1.00"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.91", 
                                                            "@upper_limit": "1.23", 
                                                            "@value": "1.07"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "60 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.18", 
                                                            "@upper_limit": "1.55", 
                                                            "@value": "1.36"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.12", 
                                                            "@upper_limit": "1.49", 
                                                            "@value": "1.31"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "90 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.18", 
                                                            "@upper_limit": "1.57", 
                                                            "@value": "1.38"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.16", 
                                                            "@upper_limit": "1.54", 
                                                            "@value": "1.35"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "120 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.19", 
                                                            "@upper_limit": "1.57", 
                                                            "@value": "1.38"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.16", 
                                                            "@upper_limit": "1.54", 
                                                            "@value": "1.35"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "150 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.19", 
                                                            "@upper_limit": "1.59", 
                                                            "@value": "1.39"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.21", 
                                                            "@upper_limit": "1.60", 
                                                            "@value": "1.40"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "180 minutes after entering chamber room"
                                            }
                                        ]
                                    }, 
                                    "description": "The TNSS is the sum of the three nasal symptom scores for nasal congestion, nasal discharge and sneezing. The possible TNSS ranged from 0 to 12, with a higher score indicting more severe total nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in TNSS at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period", 
                        "title": "Change From Baseline in TNSS at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "TNSS was weighted as 2:1:1 for nasal congestion, nasal discharge and sneezing. The possible Weighted TNSS ranged from 0 to 16, with a higher score indicating more severe total nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Weighted TNSS was assessed on Day 7 of a treatment period at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.67", 
                                                            "@upper_limit": "1.05", 
                                                            "@value": "0.86"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.72", 
                                                            "@upper_limit": "1.11", 
                                                            "@value": "0.91"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "30 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.31", 
                                                            "@upper_limit": "1.79", 
                                                            "@value": "1.55"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.40", 
                                                            "@upper_limit": "1.87", 
                                                            "@value": "1.63"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "60 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.83", 
                                                            "@upper_limit": "2.38", 
                                                            "@value": "2.11"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.76", 
                                                            "@upper_limit": "2.32", 
                                                            "@value": "2.04"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "90 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.87", 
                                                            "@upper_limit": "2.47", 
                                                            "@value": "2.17"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.87", 
                                                            "@upper_limit": "2.47", 
                                                            "@value": "2.17"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "120 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.92", 
                                                            "@upper_limit": "2.51", 
                                                            "@value": "2.21"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.86", 
                                                            "@upper_limit": "2.46", 
                                                            "@value": "2.16"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "150 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.91", 
                                                            "@upper_limit": "2.53", 
                                                            "@value": "2.22"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "1.90", 
                                                            "@upper_limit": "2.52", 
                                                            "@value": "2.21"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "180 minutes after entering chamber room"
                                            }
                                        ]
                                    }, 
                                    "description": "TNSS was weighted as 2:1:1 for nasal congestion, nasal discharge and sneezing. The possible Weighted TNSS ranged from 0 to 16, with a higher score indicating more severe total nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Weighted TNSS was assessed on Day 7 of a treatment period at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Weighted TNSS at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period", 
                        "title": "Change From Baseline in Weighted TNSS at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The Nasal Congestion Score was assessed as 0 = No symptoms of nasal congestion to 4 = Completely obstructed all day. The possible Nasal Congestion Score ranged from 0 to 4, with a higher score indicating more severe nasal congestion.The Nasal Congestion Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.24", 
                                                            "@upper_limit": "0.39", 
                                                            "@value": "0.32"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.25", 
                                                            "@upper_limit": "0.40", 
                                                            "@value": "0.33"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "30 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.46", 
                                                            "@upper_limit": "0.63", 
                                                            "@value": "0.55"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.48", 
                                                            "@upper_limit": "0.65", 
                                                            "@value": "0.56"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "60 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.64", 
                                                            "@upper_limit": "0.85", 
                                                            "@value": "0.74"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.63", 
                                                            "@upper_limit": "0.83", 
                                                            "@value": "0.73"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "90 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.68", 
                                                            "@upper_limit": "0.91", 
                                                            "@value": "0.80"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.70", 
                                                            "@upper_limit": "0.94", 
                                                            "@value": "0.82"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "120 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.72", 
                                                            "@upper_limit": "0.95", 
                                                            "@value": "0.83"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.70", 
                                                            "@upper_limit": "0.93", 
                                                            "@value": "0.81"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "150 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.70", 
                                                            "@upper_limit": "0.95", 
                                                            "@value": "0.83"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.69", 
                                                            "@upper_limit": "0.93", 
                                                            "@value": "0.81"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "180 minutes after entering chamber room"
                                            }
                                        ]
                                    }, 
                                    "description": "The Nasal Congestion Score was assessed as 0 = No symptoms of nasal congestion to 4 = Completely obstructed all day. The possible Nasal Congestion Score ranged from 0 to 4, with a higher score indicating more severe nasal congestion.The Nasal Congestion Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Nasal Congestion Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period", 
                        "title": "Change From Baseline in Nasal Congestion Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The Nasal Discharge Score was assessed as 0 = 0 times participant blew his/her nose to 4 = 21 or more times participant blew his/her nose. The possible Nasal Discharge Score ranged from 0 to 4, with a higher score indicating more severe nasal discharge.The Nasal Discharge Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.08", 
                                                            "@upper_limit": "0.18", 
                                                            "@value": "0.13"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.12", 
                                                            "@upper_limit": "0.22", 
                                                            "@value": "0.17"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "30 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.21", 
                                                            "@upper_limit": "0.34", 
                                                            "@value": "0.27"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.27", 
                                                            "@upper_limit": "0.40", 
                                                            "@value": "0.33"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "60 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.32", 
                                                            "@upper_limit": "0.46", 
                                                            "@value": "0.39"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.31", 
                                                            "@upper_limit": "0.45", 
                                                            "@value": "0.38"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "90 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.27", 
                                                            "@upper_limit": "0.40", 
                                                            "@value": "0.34"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.29", 
                                                            "@upper_limit": "0.42", 
                                                            "@value": "0.36"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "120 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.24", 
                                                            "@upper_limit": "0.37", 
                                                            "@value": "0.31"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.25", 
                                                            "@upper_limit": "0.39", 
                                                            "@value": "0.32"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "150 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.26", 
                                                            "@upper_limit": "0.40", 
                                                            "@value": "0.33"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.30", 
                                                            "@upper_limit": "0.44", 
                                                            "@value": "0.37"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "180 minutes after entering chamber room"
                                            }
                                        ]
                                    }, 
                                    "description": "The Nasal Discharge Score was assessed as 0 = 0 times participant blew his/her nose to 4 = 21 or more times participant blew his/her nose. The possible Nasal Discharge Score ranged from 0 to 4, with a higher score indicating more severe nasal discharge.The Nasal Discharge Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Nasal Discharge Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period", 
                        "title": "Change From Baseline in Nasal Discharge Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The Sneezing Score was assessed as 0 = 0 times participant sneezed to 4 = 21 or more times participant sneezed. The possible Sneezing Score ranged from 0 to 4, with a higher score indicating more severe sneezing. The Sneezing Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                                    "title": "Montelukast"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "211"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.05", 
                                                            "@upper_limit": "0.14", 
                                                            "@value": "0.09"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.05", 
                                                            "@upper_limit": "0.14", 
                                                            "@value": "0.09"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "30 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.12", 
                                                            "@upper_limit": "0.23", 
                                                            "@value": "0.18"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.12", 
                                                            "@upper_limit": "0.23", 
                                                            "@value": "0.18"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "60 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.16", 
                                                            "@upper_limit": "0.29", 
                                                            "@value": "0.23"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.13", 
                                                            "@upper_limit": "0.26", 
                                                            "@value": "0.20"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "90 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.19", 
                                                            "@upper_limit": "0.31", 
                                                            "@value": "0.25"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.11", 
                                                            "@upper_limit": "0.23", 
                                                            "@value": "0.17"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "120 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.18", 
                                                            "@upper_limit": "0.30", 
                                                            "@value": "0.24"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.15", 
                                                            "@upper_limit": "0.27", 
                                                            "@value": "0.21"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "150 minutes after entering chamber room"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "0.17", 
                                                            "@upper_limit": "0.30", 
                                                            "@value": "0.23"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0.16", 
                                                            "@upper_limit": "0.29", 
                                                            "@value": "0.23"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "180 minutes after entering chamber room"
                                            }
                                        ]
                                    }, 
                                    "description": "The Sneezing Score was assessed as 0 = 0 times participant sneezed to 4 = 21 or more times participant sneezed. The possible Sneezing Score ranged from 0 to 4, with a higher score indicating more severe sneezing. The Sneezing Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Change From Baseline in Sneezing Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                                    "units": "score on a scale"
                                }
                            ]
                        }, 
                        "population": "The FAS population consisted of all randomized participants who took at least one dose of study drug, and had a baseline assessment and at least one post-baseline assessment in a treatment period.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period", 
                        "title": "Change From Baseline in Sneezing Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Participants receive montelukast 5 mg chewable tablets for 7 days during Period 1 and receive placebo chewable tablets for 7 days during Period 2. There is a 7-day washout period between Periods 1 and 2.", 
                            "title": "Montelukast/Placebo"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Participants receive placebo chewable tablets for 7 days during Period 1 and receive montelukast 5 mg chewable tablets for 7 days during Period 2. There is a 7-day washout period between Periods 1 and 2.", 
                            "title": "Placebo/Montelukast"
                        }
                    ]
                }, 
                "period_list": {
                    "period": [
                        {
                            "drop_withdraw_reason_list": {
                                "drop_withdraw_reason": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Adverse Event"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Physician Decision"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "3", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Withdrawal by Subject"
                                    }
                                ]
                            }, 
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "110", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "110", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "108", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "106", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "2", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "4", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Period 1 (7 Days)"
                        }, 
                        {
                            "drop_withdraw_reason_list": {
                                "drop_withdraw_reason": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "2", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Adverse Event"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Physician Decision"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Withdrawal by Subject"
                                    }
                                ]
                            }, 
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "108", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "106", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "104", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "104", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "4", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "2", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Period 2 (7 Days)"
                        }
                    ]
                }
            }, 
            "point_of_contact": {
                "email": "ClinicalTrialsDisclosure@merck.com", 
                "name_or_title": "Senior Vice President, Global Clinical Development", 
                "organization": "Merck Sharp & Dohme Corp", 
                "phone": "1-800-672-6372"
            }, 
            "reported_events": {
                "desc": "The All Patients as Treated (APaT) population consisted of all randomized participants who received at least one dose of study drug.", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Participants receive montelukast 5 mg for 7 days, regardless of sequence.", 
                            "title": "Montelukast"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Participants receive placebo for 7 days, regardless of sequence.", 
                            "title": "Placebo"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "10", 
                                                "@subjects_at_risk": "216"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "17", 
                                                "@subjects_at_risk": "218"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "10", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "10", 
                                                "@subjects_at_risk": "216"
                                            }, 
                                            {
                                                "@events": "17", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "17", 
                                                "@subjects_at_risk": "218"
                                            }
                                        ], 
                                        "sub_title": "Protein urine present"
                                    }
                                }, 
                                "title": "Investigations"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 16.0", 
                    "frequency_threshold": "5"
                }, 
                "time_frame": "Up to 14 days after last dose of study drug (Up to 5 weeks)"
            }
        }, 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Seasonal Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis, Allergic, Seasonal", 
                "Rhinitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Weight: \u2265 25 kg\n\n          -  Height: \u2265 125 cm\n\n          -  Able to record symptoms in a diary\n\n          -  Has had allergic rhinitis symptoms [Japanese Cedar (JC) pollinosis]\n\n          -  Tested positive for JC pollen specific immunoglobulin E (IgE) antibody assay\n\n        Exclusion Criteria:\n\n          -  Has nasal findings that would interfere with evaluating nasal congestion symptoms\n\n          -  Past or present medical history of bronchial asthma\n\n          -  Medical history of allergies except allergic rhinitis and has possibility of\n             dramatically worsening of these symptoms induced by JC pollen exposure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "15 Years", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "220", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 16, 2013", 
        "firstreceived_results_date": "March 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01857063", 
            "org_study_id": "0476-519"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Montelukast/Placebo", 
                    "Placebo/Montelukast"
                ], 
                "description": "Montelukast 5 mg chewable tablets, taken orally once daily at bedtime for 7 days", 
                "intervention_name": "Montelukast", 
                "intervention_type": "Drug", 
                "other_name": "montelukast sodium"
            }, 
            {
                "arm_group_label": [
                    "Montelukast/Placebo", 
                    "Placebo/Montelukast"
                ], 
                "description": "Matching placebo chewable tablets, taken orally once daily at bedtime for 7 days", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Montelukast"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 30, 2014", 
        "number_of_arms": "2", 
        "official_title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled Cross-over Clinical Trial to Study the Efficacy and Safety of MK-0476 in Japanese Pediatric Subjects With Seasonal Allergic Rhinitis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Pharmaceuticals and Medical Devices Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "The TNSS is the sum of the three nasal symptom scores for nasal congestion, nasal discharge and sneezing. Participants completed a questionnaire about their nasal symptoms. Score ranged from 0 to 4 for each of the three nasal symptoms, with a total possible score ranging from 0 to 12 and a higher score indicating more severe nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period during 3 hours of exposure to Japanes cedar (JC) pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Total Nasal Symptom Score (TNSS) Averaged During 3 Hours of Exposure", 
                "safety_issue": "No", 
                "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period"
            }, 
            {
                "description": "An adverse event is defined as any unfavorable and unintended change in the structure, function, or chemistry of the body temporally associated with the use of the study drug, whether or not considered related to the use of the product. Participants were monitored for occurrence adverse events for up to 14 days after last dose of study drug. Analysis was done by study drug as taken.", 
                "measure": "Percentage of Participants Who Experience at Least One Adverse Event", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 5 weeks"
            }
        ], 
        "removed_countries": {
            "country": "Japan"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01857063"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "TNSS was weighted as 2:1:1 for nasal congestion, nasal discharge and sneezing. The Weighted TNSS ranged from 0 to 16, with a higher score indicating more severe weighted total nasal symptoms. The baseline Weighted TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Weighted TNSS Averaged During 3 Hours of Exposure", 
                "safety_issue": "No", 
                "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period"
            }, 
            {
                "description": "The Nasal Congestion Score was assessed as 0 = No symptoms of nasal congestion to 4 = Completely obstructed all day, with a possible Nasal Congestion Score ranging from 0 to 4 and a higher score indicating more severe nasal congestion. The baseline Nasal Congestion Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Nasal Congestion Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Nasal Congestion Score Averaged During 3 Hours of Exposure", 
                "safety_issue": "No", 
                "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period"
            }, 
            {
                "description": "The Nasal Discharge Score was assessed as 0 = 0 times participant blew his/her nose to 4 = 21 or more times participant blew his/her nose, with a possible Nasal Discharge Score ranging from 0 to 4 and a higher score indicating more severe nasal discharge. The baseline Nasal Discharge Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Nasal Discharge Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Nasal Discharge Score Averaged During 3 Hours of Exposure", 
                "safety_issue": "No", 
                "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period"
            }, 
            {
                "description": "The Sneezing Score was assessed as 0 = 0 times participant sneezed to 4 = 21 or more times participant sneezed, with a possible Sneezing Score ranging from 0 to 4 and a higher score indicating more severe sneezing. The baseline Sneezing Score was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Sneezing Score was assessed on Day 7 of a treatment period during 3 hours of exposure to JC pollen in the chamber room, as an average of measurements at 30, 60, 90, 120, 150 and 180 minutes. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Sneezing Score Averaged During 3 Hours of Exposure", 
                "safety_issue": "No", 
                "time_frame": "Baseline and after 3 hours of pollen exposure on Day 7 of each treatment period"
            }, 
            {
                "description": "The TNSS is the sum of the three nasal symptom scores for nasal congestion, nasal discharge and sneezing. The possible TNSS ranged from 0 to 12, with a higher score indicting more severe total nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline TNSS was assessed on Day 7 of a treatment period at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in TNSS at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                "safety_issue": "No", 
                "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period"
            }, 
            {
                "description": "TNSS was weighted as 2:1:1 for nasal congestion, nasal discharge and sneezing. The possible Weighted TNSS ranged from 0 to 16, with a higher score indicating more severe total nasal symptoms. The baseline TNSS was assessed on Day 7 of a treatment period prior to entering the chamber room. The post-baseline Weighted TNSS was assessed on Day 7 of a treatment period at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Weighted TNSS at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                "safety_issue": "No", 
                "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period"
            }, 
            {
                "description": "The Nasal Congestion Score was assessed as 0 = No symptoms of nasal congestion to 4 = Completely obstructed all day. The possible Nasal Congestion Score ranged from 0 to 4, with a higher score indicating more severe nasal congestion.The Nasal Congestion Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Nasal Congestion Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                "safety_issue": "No", 
                "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period"
            }, 
            {
                "description": "The Nasal Discharge Score was assessed as 0 = 0 times participant blew his/her nose to 4 = 21 or more times participant blew his/her nose. The possible Nasal Discharge Score ranged from 0 to 4, with a higher score indicating more severe nasal discharge.The Nasal Discharge Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Nasal Discharge Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                "safety_issue": "No", 
                "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period"
            }, 
            {
                "description": "The Sneezing Score was assessed as 0 = 0 times participant sneezed to 4 = 21 or more times participant sneezed. The possible Sneezing Score ranged from 0 to 4, with a higher score indicating more severe sneezing. The Sneezing Score was assessed on Day 7 prior to entering the chamber room and at 30, 60, 90, 120, 150 and 180 minutes after entering the chamber room. Analysis was done by study drug as taken.", 
                "measure": "Change From Baseline in Sneezing Score at 30, 60, 90, 120, 150 and 180 Minutes After Entering Chamber Room", 
                "safety_issue": "No", 
                "time_frame": "Baseline and at 30, 60, 90, 120, 150 and 180 minutes after entering chamber room on Day 7 of a treatment period"
            }
        ], 
        "source": "Merck Sharp & Dohme Corp.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Merck Sharp & Dohme Corp.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}